Ob/Gyn & Women's Health News

 
  • ACR Romosozumab and Alendronate Curb Fracture in Osteoporosis A sequential regimen of romosozumab followed by alendronate is more effective than alendronate alone for increasing bone mass in women with osteoporosis, results from the ARCH trial show.
  • Adequate Vitamin D Tied to Higher Live Birth Rate After ART Among women undergoing assisted reproduction treatment, those with adequate vitamin D levels were a third more likely to deliver a live baby than those with deficient or insufficient levels, a study found.
 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Blood-Brain Barrier Breakdown Common in RCVSThe study is the first to document the effect, observed on contrast-enhanced MRI in 70% of patients confirmed with reversible cerebral vasoconstriction syndrome, suggesting an important diagnostic clue.
  • Benign MS: Does It Exist?New data on estimates of benign MS have provoked strong conflicting opinions on its actual incidence and the recommended treatment approaches.
  • Triptans Safe in PregnancyTriptans to treat migraine during pregnancy appear to have no major teratogenic effects, new research shows.

Perspective

Business of Medicine

Columnists

Advisory Board

 

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape